BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 15356132)

  • 1. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.
    Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T
    J Immunol; 2004 Sep; 173(6):3844-54. PubMed ID: 15356132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
    Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
    J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.
    Ohtani T; Ishihara K; Atsumi T; Nishida K; Kaneko Y; Miyata T; Itoh S; Narimatsu M; Maeda H; Fukada T; Itoh M; Okano H; Hibi M; Hirano T
    Immunity; 2000 Jan; 12(1):95-105. PubMed ID: 10661409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex.
    Bode JG; Schweigart J; Kehrmann J; Ehlting C; Schaper F; Heinrich PC; Häussinger D
    J Immunol; 2003 Jul; 171(1):257-66. PubMed ID: 12817006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell maturation requires STAT1 and is under feedback regulation by suppressors of cytokine signaling.
    Jackson SH; Yu CR; Mahdi RM; Ebong S; Egwuagu CE
    J Immunol; 2004 Feb; 172(4):2307-15. PubMed ID: 14764699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic abnormalities in mice deficient in gp130-mediated STAT signaling.
    Jenkins BJ; Quilici C; Roberts AW; Grail D; Dunn AR; Ernst M
    Exp Hematol; 2002 Nov; 30(11):1248-56. PubMed ID: 12423677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.
    Weatherill AR; Lee JY; Zhao L; Lemay DG; Youn HS; Hwang DH
    J Immunol; 2005 May; 174(9):5390-7. PubMed ID: 15843537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells.
    Samsom JN; van Berkel LA; van Helvoort JM; Unger WW; Jansen W; Thepen T; Mebius RE; Verbeek SS; Kraal G
    J Immunol; 2005 May; 174(9):5279-87. PubMed ID: 15843524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory activity of autocrine IL-10 on dendritic cell functions.
    Corinti S; Albanesi C; la Sala A; Pastore S; Girolomoni G
    J Immunol; 2001 Apr; 166(7):4312-8. PubMed ID: 11254683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3.
    Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ
    J Immunol; 2011 Jan; 186(2):1199-208. PubMed ID: 21148800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation.
    Ernst M; Inglese M; Waring P; Campbell IK; Bao S; Clay FJ; Alexander WS; Wicks IP; Tarlinton DM; Novak U; Heath JK; Dunn AR
    J Exp Med; 2001 Jul; 194(2):189-203. PubMed ID: 11457894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
    Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
    Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel and detrimental effects of lipopolysaccharide on in vitro generation of immature dendritic cells: involvement of mitogen-activated protein kinase p38.
    Xie J; Qian J; Wang S; Freeman ME; Epstein J; Yi Q
    J Immunol; 2003 Nov; 171(9):4792-800. PubMed ID: 14568957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen-related cell adhesion molecule 1 on murine dendritic cells is a potent regulator of T cell stimulation.
    Kammerer R; Stober D; Singer BB; Obrink B; Reimann J
    J Immunol; 2001 Jun; 166(11):6537-44. PubMed ID: 11359805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PAF-receptor induces regulatory dendritic cells through PGE2 and IL-10.
    Koga MM; Bizzarro B; Sá-Nunes A; Rios FJ; Jancar S
    Prostaglandins Leukot Essent Fatty Acids; 2013 Oct; 89(5):319-26. PubMed ID: 24120121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHIP is required for dendritic cell maturation.
    Antignano F; Ibaraki M; Kim C; Ruschmann J; Zhang A; Helgason CD; Krystal G
    J Immunol; 2010 Mar; 184(6):2805-13. PubMed ID: 20154203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130.
    Kumanogoh A; Marukawa S; Kumanogoh T; Hirota H; Yoshida K; Lee IS; Yasui T; Yoshida K; Taga T; Kishimoto T
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2478-82. PubMed ID: 9122220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.